Trailing-twelve-month (TTM) revenue is $9.98 Billion with a year-over-year growth of (11.72%). Revenue represents the total income generated from the company's primary business operations.
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $2,694,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-04 |
| Q4 FY2025Period ended 2025-12-31 | $2,589,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-02-27 |
| Q1 FY2026Period ended 2026-03-31 | $2,741,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-05 |
| Q2 FY2026Period ended 2026-06-30 | $1,954,000,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-04 |
| TTM revenue | $9,978,000,000 |
Current P/S: $21,524,595,930 market capitalization ÷ $9,978,000,000 TTM revenue = 2.16x.
Market capitalization source: FMP quote. Quote observed 2026-09-09T20:00:02.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.
Reported quarterly revenue; no daily interpolation. Q2 FY2026 (2026-06-30): $1.95B.
FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Selected amounts supplied by FMP for each displayed period. Reviewed label references appear where available; other labels are unverified, and items may overlap.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Flavors | $3.1B | N/A | N/A | N/A | N/A | N/A |
| Food Ingredients | N/A | N/A |
FMP selected disclosures by reporting period. Rows match exact source labels; they may overlap. N/A means no matching disclosure, not zero. Filing links identify reviewed presentation labels for that period.
| FMP source label (unverified unless linked) | FY20202020-12-31 · USD | FY20212021-12-31 · USD | FY20222022-12-31 · USD | FY20232023-12-31 · USD | FY20242024-12-31 · USD | FY20252025-12-31 · USD |
|---|---|---|---|---|---|---|
| Asia | $1.2B | $2.7B | $2.9B | $2.7B | $2.7B | $2.5B |
| EMEA | $2.0B | $4.1B | $4.2B | $3.8B |
$9.98B
$9.98 Billion
(11.72%)
vs. $11.30B a year ago (TTM)
+4.28%
5 Year compound annual growth rate
1 Year
(11.72%)
3 Year
(5.60%)
5 Year
+4.28%
10 Year
+12.56%
15 Year
+9.02%
20 Year
+8.38%
CAGR shows the annualized growth rate over the specified period, smoothing out year-to-year volatility.
| Year | Revenue | YoY Change | % Change |
|---|---|---|---|
| 2025 | $10.89B | ($594.00M) | (5.17%) |
| 2024 | $11.48B | +$5.00M | +0.04% |
| 2023 | $11.48B | ($961.00M) | (7.73%) |
| 2022 | $12.44B | +$784.00M | +6.73% |
| 2021 | $11.66B | +$6.57B | +129.27% |
| 2020 |
TTM Growth
(11.72%)
3-Year CAGR
(5.60%)
5-Year CAGR
+4.28%
Revenue growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
Current FMP quote-based enterprise value / four-quarter revenue Quote observation: 2026-09-09T20:00:02.000Z. Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation. Historical series through 2026-09-09.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
2025-12-31 · USD
Reviewed labels link to their filing; other labels are unverified FMP source labels.
Reviewed presentation labels and parent/child details link to filing evidence; other FMP source labels remain unverified. Mutual exclusivity and reconciliation to a total for the same reporting period and currency have not been verified; percentages and stacked totals are unavailable.
| N/A |
| N/A |
| N/A |
| $3.3B |
| Fragrances | $2.0B | N/A | N/A | N/A | N/A | N/A |
|---|
| Health & Biosciences | N/A | $2.3B | $2.3B | $2.1B | $2.1B | $2.3B |
|---|
| Nourish | N/A | $6.3B | $6.8B | $6.1B | $5.9B | N/A |
|---|
| Pharma Solutions | N/A | $809M | $971M | $945M | $961M | $369M |
|---|
| Scent | N/A | $2.3B | $2.3B | $2.4B | $2.4B | $2.5B |
|---|
| Taste | N/A | N/A | N/A | N/A | N/A | $2.5B |
|---|
| $3.7B |
| Latin America | $707M | $1.3B | $1.5B | $1.5B | $1.5B | $1.4B |
|---|
| North America | $1.2B | $3.5B | $3.9B | $3.5B | $3.4B | $3.2B |
|---|
| UNITED STATES | N/A | N/A | N/A | N/A | N/A | $3.1B |
|---|
| $5.08B |
| ($56.00M) |
| (1.09%) |
| 2019 | $5.14B | +$1.16B | +29.23% |
| 2018 | $3.98B | +$578.82M | +17.03% |
| 2017 | $3.40B | +$282.37M | +9.06% |
| 2016 | $3.12B | +$93.16M | +3.08% |
